ATE517899T1 - Hiv-integrasehemmer - Google Patents
Hiv-integrasehemmerInfo
- Publication number
- ATE517899T1 ATE517899T1 AT06792296T AT06792296T ATE517899T1 AT E517899 T1 ATE517899 T1 AT E517899T1 AT 06792296 T AT06792296 T AT 06792296T AT 06792296 T AT06792296 T AT 06792296T AT E517899 T1 ATE517899 T1 AT E517899T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- hiv
- inhibitors
- hiv integrase
- integrase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72356705P | 2005-10-04 | 2005-10-04 | |
PCT/EP2006/009410 WO2007039218A1 (en) | 2005-10-04 | 2006-09-26 | Hiv integrase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE517899T1 true ATE517899T1 (de) | 2011-08-15 |
Family
ID=37621988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06792296T ATE517899T1 (de) | 2005-10-04 | 2006-09-26 | Hiv-integrasehemmer |
Country Status (7)
Country | Link |
---|---|
US (1) | US7939537B2 (de) |
EP (1) | EP1937678B1 (de) |
JP (1) | JP5094725B2 (de) |
AT (1) | ATE517899T1 (de) |
AU (1) | AU2006299042B8 (de) |
CA (1) | CA2622639C (de) |
WO (1) | WO2007039218A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR064517A1 (es) | 2006-12-22 | 2009-04-08 | Avexa Ltd | Pirimidinionas biciclicas y sus usos |
EP2079737A1 (de) * | 2007-02-05 | 2009-07-22 | Xenon Pharmaceuticals Inc. | Für die behandlung von über natriumkanäle vermittelten krankheiten oder leiden geeignete pyridopyrimidinonverbindungen |
JP5269086B2 (ja) | 2007-11-15 | 2013-08-21 | ギリアード サイエンシス インコーポレーテッド | ヒト免疫不全ウイルスの複製阻害薬 |
WO2009062288A1 (en) | 2007-11-15 | 2009-05-22 | Boehringer Ingelheim International Gmbh | Inhibitors of human immunodeficiency virus replication |
EA201200631A1 (ru) | 2007-11-16 | 2012-11-30 | Джилид Сайенсиз, Инк. | Ингибиторы репликации вируса иммунодефицита человека |
CA2729663A1 (en) * | 2008-07-02 | 2010-01-07 | Avexa Limited | Compounds having antiviral properties |
CN102336751A (zh) * | 2010-07-16 | 2012-02-01 | 爱维艾珂瑟有限公司 | 新型抗病毒剂 |
CA3131037A1 (en) | 2011-11-30 | 2013-06-06 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
CN115151540A (zh) | 2019-12-02 | 2022-10-04 | 风暴治疗有限公司 | 作为mettl3抑制剂的多杂环化合物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0017676D0 (en) | 2000-07-19 | 2000-09-06 | Angeletti P Ist Richerche Bio | Inhibitors of viral polymerase |
JP4252797B2 (ja) | 2000-10-12 | 2009-04-08 | メルク エンド カムパニー インコーポレーテッド | Hivインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類 |
WO2002036734A2 (en) | 2000-10-12 | 2002-05-10 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors |
WO2002055079A2 (en) | 2000-10-12 | 2002-07-18 | Merck & Co Inc | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
ATE364385T1 (de) | 2000-10-12 | 2007-07-15 | Merck & Co Inc | Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer |
JP3616628B2 (ja) * | 2001-03-01 | 2005-02-02 | 塩野義製薬株式会社 | Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物 |
BR0211750A (pt) | 2001-08-10 | 2004-10-13 | Shionogi & Co | Agente antiviral |
CN102219750B (zh) | 2001-10-26 | 2013-05-29 | P.安杰莱蒂分子生物学研究所 | 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂 |
US7232819B2 (en) | 2001-10-26 | 2007-06-19 | Istituto Di Ricerche Di Biologia P. Angeletti S.P.A. | Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
JP4170633B2 (ja) * | 2001-11-12 | 2008-10-22 | 独立行政法人科学技術振興機構 | 拡張型心筋症の原因となる新規点突然変異を有するデスミン遺伝子 |
CA2472372C (en) | 2002-01-17 | 2010-08-17 | Melissa Egbertson | Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
GB0201179D0 (en) | 2002-01-18 | 2002-03-06 | Angeletti P Ist Richerche Bio | Therapeutic agents |
US7109186B2 (en) | 2002-07-09 | 2006-09-19 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
NZ540729A (en) * | 2002-12-27 | 2008-03-28 | Angeletti P Ist Richerche Bio | Tetrahydro-4H-pyrido[1,2-a]pyrimidines and related compounds useful as HIV integrase inhibitors |
TW200510425A (en) | 2003-08-13 | 2005-03-16 | Japan Tobacco Inc | Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
TW200526635A (en) * | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
US7598264B2 (en) | 2004-03-09 | 2009-10-06 | Merck & Co., Inc. | HIV integrase inhibitors |
AU2005221864A1 (en) | 2004-03-09 | 2005-09-22 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | HIV integrase inhibitors |
EP1725535A4 (de) | 2004-03-09 | 2009-11-25 | Merck & Co Inc | Hiv-integrasehemmer |
US7176196B2 (en) | 2004-05-28 | 2007-02-13 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
US7192948B2 (en) | 2004-05-28 | 2007-03-20 | Bristol-Myers Squibb Company | Bicyclic heterocycles as HIV integrase inhibitors |
SI3045206T1 (en) | 2005-04-28 | 2018-07-31 | Viiv Healthcare Company | A polycyclic carbamoylpyridone derivative with inhibitory activity for the HIV integrase |
-
2006
- 2006-09-26 AT AT06792296T patent/ATE517899T1/de not_active IP Right Cessation
- 2006-09-26 US US11/992,531 patent/US7939537B2/en active Active
- 2006-09-26 JP JP2008533912A patent/JP5094725B2/ja not_active Expired - Fee Related
- 2006-09-26 EP EP06792296A patent/EP1937678B1/de not_active Not-in-force
- 2006-09-26 AU AU2006299042A patent/AU2006299042B8/en not_active Ceased
- 2006-09-26 WO PCT/EP2006/009410 patent/WO2007039218A1/en active Application Filing
- 2006-09-26 CA CA2622639A patent/CA2622639C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1937678B1 (de) | 2011-07-27 |
JP2009510148A (ja) | 2009-03-12 |
WO2007039218A1 (en) | 2007-04-12 |
AU2006299042B8 (en) | 2011-09-15 |
CA2622639C (en) | 2012-01-03 |
JP5094725B2 (ja) | 2012-12-12 |
AU2006299042A1 (en) | 2007-04-12 |
EP1937678A1 (de) | 2008-07-02 |
US20090221571A1 (en) | 2009-09-03 |
CA2622639A1 (en) | 2007-04-12 |
AU2006299042A8 (en) | 2011-09-15 |
US7939537B2 (en) | 2011-05-10 |
AU2006299042B2 (en) | 2011-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2020026I1 (no) | Raltegravir eller et farmasøytisk akseptabelt salt derav, spesielt kaliumsaltet | |
WO2005086700A3 (en) | Hiv integrase inhibitors | |
WO2006103399A8 (en) | Hiv integrase inhibitors | |
TN2009000243A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2007146230A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2008054605A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
MD4625C1 (ro) | Derivaţi de 5-fenoxi-3H-pirimidin-4-onă şi utilizarea acestora ca inhibitori ai transcriptazei inverse a HIV | |
WO2006121831A3 (en) | Hiv integrase inhibitors | |
TW200738702A (en) | HIV reverse transcriptase inhibitors | |
WO2005074513A3 (en) | N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors | |
MY163979A (en) | Non-nucleoside reverse transcriptase inhibitors | |
EA200601654A1 (ru) | Ингибиторы интегразы вич | |
ATE517899T1 (de) | Hiv-integrasehemmer | |
WO2010042391A3 (en) | Hiv integrase inhibitors | |
WO2007050510A3 (en) | Hiv integrase inhibitors | |
WO2005110414A3 (en) | Hiv integrase inhibitors | |
WO2009042094A3 (en) | Hiv protease inhibitors | |
WO2007002458A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2011025683A8 (en) | Hiv integrase inhibitors | |
WO2005120516A3 (en) | Hiv integrase inhibitors | |
WO2007002481A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2007021629A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
WO2007002368A3 (en) | Non-nucleoside reverse transcriptase inhibitors | |
TW200640460A (en) | HIV integrase inhibitors | |
TNSN06270A1 (en) | Hiv integrase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |